University of Cincinnati - PARENT — Cincinnati, Ohio

University of Cincinnati - PARENT is a clinical research site located in Cincinnati, Ohio, United States 45229.

Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Cincinnati - PARENT has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Solid Tumors, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV.

Sponsors: EMD Serono Research & Development Institute, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cincinnati

Browse all research sites in Ohio · View every site in Cincinnati

• The Jewish Hospital - Mercy
• The Linder Center for Education and Research at The Christ Hospital
• University of Cincinnati Health Center
• Good Samaritan Hospital Cancer Treatment Center, Hatton Institute
• Veterans Administration Hospital of Cincinnati
• The Lindner Research Center at Christ Hospital
• Cincinnati Children's Hospital Medical Center Liberty Campus
• University of Cincinnati Cancer Center CTO
• University of Cincinnati Mayfield Clinic and Spine Institute
• University of Cincinnati Health Barrett Cancer Center
• Deaconess Hospital
• Veterans Administration Medical Center - Cincinnati

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Cincinnati - PARENT?

University of Cincinnati - PARENT has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Cincinnati - PARENT conducted?

University of Cincinnati - PARENT has 2 clinical trials on record, with 2 currently active. Their work covers Solid Tumors, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV.

Is University of Cincinnati - PARENT accredited by Crixeo Clinical Trials?

University of Cincinnati - PARENT has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Cincinnati - PARENT?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.